Clinical trial
Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery
NCT07052513 is registered in ClinicalTrials.gov with M2RLAB SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery
- Lead sponsor
- M2RLAB SL
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- December 14, 2025
- Completion date
- September 2, 2028
- Enrollment
- 98 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.